Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00217698 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: gefitinib
DRUG: gemcitabine hydrochloride

Sponsor

Swiss Cancer Institute